- Release Date: 08/04/24 08:57
- Summary: SYNThesis BioVentures MoU for cellular immunotherapies
- Price Sensitive: Yes
- Download Document 211.2KB
Ann: SYNThesis BioVentures MoU for cellular immunotherapies
- There are more pages in this discussion • 124 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 1AD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.9¢ |
Change
0.002(7.41%) |
Mkt cap ! $14.75M | |||
| Open | High | Low | Value | Volume |
| 2.8¢ | 2.9¢ | 2.8¢ | $43.30K | 1.503M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 721435 | 2.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.9¢ | 486671 | 1 |
View Market Depth
| Last trade - 13.18pm 30/04/2024 (20 minute delay) ? |
|
|||||
|
Last
2.9¢ |
Change
0.002 ( 3.57 %) |
||||
| Open | High | Low | Volume | ||
| 2.8¢ | 2.9¢ | 2.8¢ | 285755 | ||
| Last updated 12.43pm 30/04/2024 ? | |||||
| 1AD (ASX) Chart |